| 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative D Aletaha, T Neogi, AJ Silman, J Funovits, DT Felson, CO Bingham III, ... Arthritis & rheumatism 62 (9), 2569-2581, 2010 | 14521 | 2010 |
| EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics … B Combe, R Landewé, C Lukas, HD Bolosiu, F Breedveld, M Dougados, ... Annals of the rheumatic diseases 66 (1), 34-45, 2007 | 1183 | 2007 |
| Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study A Naranjo, T Sokka, MA Descalzo, J Calvo-Alén, K Hørslev-Petersen, ... Arthritis research & therapy 10, 1-10, 2008 | 713 | 2008 |
| 2016 update of the EULAR recommendations for the management of early arthritis B Combe, R Landewe, CI Daien, C Hua, D Aletaha, JM Álvaro-Gracia, ... Annals of the rheumatic diseases 76 (6), 948-959, 2017 | 645 | 2017 |
| Efficacy and safety of rituximab in type II mixed cryoglobulinemia F Zaja, S De Vita, C Mazzaro, S Sacco, D Damiani, G De Marchi, ... Blood, The Journal of the American Society of Hematology 101 (10), 3827-3834, 2003 | 592 | 2003 |
| Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis MH Buch, JS Smolen, N Betteridge, FC Breedveld, G Burmester, T Dörner, ... Annals of the rheumatic diseases 70 (6), 909-920, 2011 | 514 | 2011 |
| Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open‐label extension analysis E Keystone, R Fleischmann, P Emery, DE Furst, R Van Vollenhoven, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 438 | 2007 |
| Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis S Alivernini, L MacDonald, A Elmesmari, S Finlay, B Tolusso, MR Gigante, ... Nature medicine 26 (8), 1295-1306, 2020 | 388 | 2020 |
| Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells SD Vita, F Zaja, S Sacco, AD Candia, R Fanin, G Ferraccioli Arthritis & Rheumatism 46 (8), 2029-2033, 2002 | 379 | 2002 |
| The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report T Neogi, D Aletaha, AJ Silman, RL Naden, DT Felson, R Aggarwal, ... Arthritis & Rheumatism 62 (9), 2582-2591, 2010 | 361 | 2010 |
| Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study T Sokka, H Kautiainen, T Pincus, SMM Verstappen, A Aggarwal, R Alten, ... Arthritis research & therapy 12, 1-10, 2010 | 360 | 2010 |
| Consensus statement on the use of rituximab in patients with rheumatoid arthritis JS Smolen, EC Keystone, P Emery, FC Breedveld, N Betteridge, ... Annals of the rheumatic diseases 66 (2), 143-150, 2007 | 331 | 2007 |
| EULAR definition of difficult-to-treat rheumatoid arthritis G Nagy, NMT Roodenrijs, PMJ Welsing, M Kedves, A Hamar, ... Annals of the rheumatic diseases 80 (1), 31-35, 2021 | 312 | 2021 |
| Analysis of disability in knee osteoarthritis. Relationship with age and psychological variables but not with radiographic score. F Salaffi, F Cavalieri, M Nolli, G Ferraccioli The journal of rheumatology 18 (10), 1581-1586, 1991 | 301 | 1991 |
| Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial R Caporali, MA Cimmino, G Ferraccioli, R Gerli, C Klersy, C Salvarani, ... Annals of Internal Medicine 141 (7), 493-500, 2004 | 284 | 2004 |
| Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis G Peluso, A Michelutti, S Bosello, E Gremese, B Tolusso, G Ferraccioli Annals of the rheumatic diseases 70 (1), 172-175, 2011 | 246 | 2011 |
| B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial S Bosello, M De Santis, G Lama, C Spanò, C Angelucci, B Tolusso, ... Arthritis research & therapy 12, 1-10, 2010 | 244 | 2010 |
| A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. C Salvarani, P Macchioni, I Olivieri, A Marchesoni, M Cutolo, G Ferraccioli, ... The Journal of Rheumatology 28 (10), 2274-2282, 2001 | 235 | 2001 |
| EMG-biofeedback training in fibromyalgia syndrome. G Ferraccioli, L Ghirelli, F Scita, M Nolli, M Mozzani, S Fontana, ... The Journal of Rheumatology 14 (4), 820-825, 1987 | 235 | 1987 |
| Jean-Charles Preiser E Gremese, G Ferraccioli medicine 65, 94-100, 2013 | 232 | 2013 |
Elisa GremeseProfessore Associato, Università Cattolica del Sacro CuoreEmail verificata su unicatt.it
